Somnoware is proud to announce that our platform has been selected from hundreds of companies as a Quarterfinalist in the Clinical Diagnostic Tool/Platform category for a 2022 UCSF Digital Health Award. The Awards honor outstanding health technologies and innovations dramatically transforming healthcare.
“It’s an honor to be recognized as a quarterfinalist by UCSF Digital Health Awards,” said Andrew Plourde, Somnoware Head of Product. “Somnoware is truly revolutionizing healthcare by saving clinicians time though workflow automation and improving patient outcomes with automated digital patient interventions. The platform aggregates millions of datapoints to help improve clinical decision-making for healthcare providers in sleep and respiratory care.”
The UCSF Digital Health Awards seek the best companies that are revolutionizing digital health and therapeutics, across 11 selected award categories. Each year the organization awards the best of the best in digital health as voted by industry experts across academia, industry, the investment community, and industry analysts.
The Clinical Diagnostic Tool/Platform category recognizes a digital diagnostic technology for patient monitoring that can significantly improve decision-making in the clinical setting.
Somnoware is a cloud-based platform for enhanced respiratory care management. The platform orchestrates data flow between disparate medical devices, unifies datasets within a single platform, and delivers high-impact analytics. The solution enables screening, faster diagnosis, proactive intervention, and automated patient engagement, resulting in improved treatment outcomes for patients with sleep disorders and respiratory diseases, including COPD.
Visit somnoware.com to request a demo of the platform.
Frank Holman, Director of Marketing
Franklin Holman is director of marketing at Somnoware. He can be reached at firstname.lastname@example.org.